View Archive »
About The Cover
Analysis of TAZ subcellular localization, Alexa flour 568-conjugated phalloidin to detect cytosolic F-actin. See Xiang et al.
|
|
Table of Contents
Reviews
|
| Classification of current anticancer immunotherapies |
|
https://doi.org/10.18632/oncotarget.2998
|
| 12472-12508 |
Priority Research Papers
|
| Hypoxiainducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype |
|
https://doi.org/10.18632/oncotarget.2997
|
| 12509-12527 |
|
| A unifying gene signature for adenoid cystic cancer identifies parallel MYBdependent and MYBindependent therapeutic targets |
|
https://doi.org/10.18632/oncotarget.2985
|
| 12528-12542 |
|
| MYC regulates the noncoding transcriptome |
|
https://doi.org/10.18632/oncotarget.3033
|
| 12543-12554 |
|
| Phosphorylation of Tip60 by p38α regulates p53mediated PUMA induction and apoptosis in response to DNA damage |
|
https://doi.org/10.18632/oncotarget.2717
|
| 12555-12572 |
Research Papers: Gerotarget (Focus on Aging)
|
| Higher mortality and impaired elimination of bacteria in aged mice after intracerebral infection with E coli are associated with an agerelated decline of microglia and macrophage functions |
|
https://doi.org/10.18632/oncotarget.2709
|
| 12573-12592 |
Research Papers
|
| Multidimensional analysis of gene expression reveals TGFB1I1induced EMT contributes to malignant progression of astrocytomas |
|
https://doi.org/10.18632/oncotarget.2518
|
| 12593-12606 |
|
| BRaf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells |
|
https://doi.org/10.18632/oncotarget.2610
|
| 12607-12620 |
|
| Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells |
|
https://doi.org/10.18632/oncotarget.2181
|
| 12621-12634 |
|
| The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias |
|
https://doi.org/10.18632/oncotarget.2211
|
| 12635-12645 |
|
| PRK1/PKN1 controls migration and metastasis of androgenindependent prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.2653
|
| 12646-12664 |
|
| Androgen deprivation therapy prevents bladder cancer recurrence |
|
https://doi.org/10.18632/oncotarget.2851
|
| 12665-12674 |
|
| A role for BMPinduced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy |
|
https://doi.org/10.18632/oncotarget.2564
|
| 12675-12693 |
|
| Ferroxitosis: A cell death from modulation of oxidative phosphorylation and PKM2dependent glycolysis in melanoma |
|
https://doi.org/10.18632/oncotarget.3031
|
| 12694-12703 |
|
| Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to antiHER2 targeted therapy |
|
https://doi.org/10.18632/oncotarget.2871
|
| 12704-12714 |
|
| Tumor promoterinduced cellular senescence: cell cycle arrest followed by geroconversion |
|
https://doi.org/10.18632/oncotarget.3011
|
| 12715-12727 |
|
| The angular structure of ONC201 a TRAIL pathwayinducing compound determines its potent anticancer activity |
|
https://doi.org/10.18632/oncotarget.2890
|
| 12728-12737 |
|
| Preclinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss |
|
https://doi.org/10.18632/oncotarget.2818
|
| 12738-12752 |
|
| The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma |
|
https://doi.org/10.18632/oncotarget.2648
|
| 12753-12768 |
|
| Endbinding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vincaalkaloids in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.2646
|
| 12769-12787 |
|
| Loss of compensatory prosurvival and antiapoptotic modulator IKKε sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21 |
|
https://doi.org/10.18632/oncotarget.2665
|
| 12788-12802 |
|
| Pilot study of p62 DNA vaccine in dogs with mammary tumors |
|
https://doi.org/10.18632/oncotarget.2516
|
| 12803-12810 |
|
| DEPTOR has growth suppression activity against pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.2659
|
| 12811-12819 |
|
| Cotreatment with therapeutic neural stem cells expressing carboxyl esterase and CPT11 inhibit growth of primary and metastatic lung cancers in mice |
|
https://doi.org/10.18632/oncotarget.2547
|
| 12835-12848 |
|
| Inhibition of spontaneous and experimental lung metastasis of softtissue sarcoma by tumortargeting Salmonella typhimurium A1R |
|
https://doi.org/10.18632/oncotarget.2561
|
| 12849-12861 |
|
| VER246608 a novel panisoform ATP competitive inhibitor of pyruvate dehydrogenase kinase disrupts Warburg metabolism and induces contextdependent cytostasis in cancer cells |
|
https://doi.org/10.18632/oncotarget.2656
|
| 12862-12876 |
|
| Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres cancer stem cells irrespective of EGFR KRAS EML4/ALK and LKB1 status |
|
https://doi.org/10.18632/oncotarget.2657
|
| 12877-12890 |
|
| Antiproliferative and gene expression actions of resveratrol in breast cancer cells in vitro |
|
https://doi.org/10.18632/oncotarget.2632
|
| 12891-12907 |
|
| MicroRNA expression patterns in the malignant progression of gliomas and a 5microRNA signature for prognosis |
|
https://doi.org/10.18632/oncotarget.2679
|
| 12908-12915 |
|
| AuroraA promotes chemoresistance in hepatocelluar carcinoma by targeting NFkappaB/microRNA21/PTEN signaling pathway |
|
https://doi.org/10.18632/oncotarget.2682
|
| 12916-12935 |
|
| Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basallike breast cancer treated with radiotherapy |
|
https://doi.org/10.18632/oncotarget.2683
|
| 12936-12949 |
|
| LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myelomabone disease |
|
https://doi.org/10.18632/oncotarget.2633
|
| 12950-12967 |
Clinical Research Papers
|
| Peripheral primitive neuroectodermal tumor: Dynamic CT MRI and clinicopathological characteristics analysis of 36 cases and review of the literature |
|
https://doi.org/10.18632/oncotarget.2649
|
| 12968-12977 |
|
| Prognostic impact of a compartmentspecific angiogenic marker profile in patients with pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.2651
|
| 12978-12989 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
